+(91) 79 4891 1722

info@ralingtonpharma.com

(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt

Intermediate of EscitalopramOxalate

Ralington pharma LLP(India), a global manufacturer and supplier for (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)-3-hydroxymethyl)-benzonitrilehemi D-(+)-di-p-toloyltartaric acid salt, 128173-53-5 for R&D, Pilot orCommercials  Quantities.

(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)-3-hydroxymethyl)-benzonitrilehemi D-(+)-di-p-toloyltartaric acid salt, 128173-53-5 available with USFDA, EUGMP, GMP, ISO CERTIFIED and WHO-GMP as per the requirement. Product supply in StandardPackaging & labeling as per FDA along with supportive documentation. We can also offer API of  (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)-3-hydroxymethyl)-benzonitrilehemi D-(+)-di-p-toloyltartaric acid salt, 128173-53-5.

ProductType : Intermediates
Molecular Formula : 2(C20H23FN2O2).C20H18O8
CASNo : 128173-53-5
Grades :
Molecular Weight : 1071.18
Synonym : 4-[(4-Dimethylamino)-1(4-fluorophenyl) -1-hydroxybutyl]-3-(hydroxymethyl)- benzonitrile-D-hemi tartaricacid,(S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1),,

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Top